Swedish test may boost pancreatic cancer survival rates

Swedish researchers have developed a new method for diagnosing pancreatic cancer at a much earlier stage than currently possible, the University of Gothenburg said Tuesday.

The test detects the first signs of the with 97 percent accuracy, which researchers hope will help improve the low survival rate among those diagnosed.

Only five percent of patients with pancreatic cancer survive more than five years after their diagnosis as tumours often develop unnoticed and spread to other organs before being detected.

"We are very hopeful that the method will enable more instances of early discovery of at a stage when the cancer can be treated or prevented," Karolina Jabbar, part of the research team at the Sahlgrenska Academy, said in a statement.

"Thanks to this analysis, we can see at what stage the is," she told AFP.

The test works like a normal endoscopy, where a tube is placed inside a patient's mouth and then fed down into the stomach.

"The difference is that the tube takes ultra sound (images) so you can see the organ much better and then you can take off fluids," said Jabbar.

The procedure is not only expected to help detect cancers early but also reduce the risk of unnecessary surgery.

Existing tumours can be tested with the method, with an of about 90 percent, making it easier to determine if a patient needs immediate surgery.

add to favorites email to friend print save as pdf

Related Stories

Pancreatic cancer surgery findings presented at SSO

Mar 13, 2014

Despite the benefits of surgery for early stage pancreatic cancer, it remains under-utilized for patients with this deadly disease, according to a new national analysis of trends and outcomes. Physician-scientists at University ...

A simple test may catch early pancreatic cancer

Oct 23, 2013

Reporting on a small preliminary study, Johns Hopkins researchers say a simple blood test based on detection of tiny epigenetic alterations may reveal the earliest signs of pancreatic cancer, a disease that is nearly always ...

Recommended for you

Immune checkpoint inhibitors may work in brain cancers

8 hours ago

New evidence that immune checkpoint inhibitors may work in glioblastoma and brain metastases was presented today by Dr Anna Sophie Berghoff at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

New model of follow up for breast cancer patients

12 hours ago

Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.